Share on StockTwits

The Advisory Board Company (NASDAQ:ABCO) President David L. Felsenthal sold 4,272 shares of the company’s stock on the open market in a transaction dated Thursday, August 21st. The stock was sold at an average price of $49.86, for a total transaction of $213,001.92. Following the sale, the president now directly owns 32,585 shares in the company, valued at approximately $1,624,688. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

The Advisory Board Company (NASDAQ:ABCO) traded up 0.84% during mid-day trading on Friday, hitting $50.69. 84,013 shares of the company’s stock traded hands. The Advisory Board Company has a 52-week low of $46.37 and a 52-week high of $70.55. The stock has a 50-day moving average of $50.30 and a 200-day moving average of $56.01. The company has a market cap of $1.840 billion and a P/E ratio of 104.08.

The Advisory Board Company (NASDAQ:ABCO) last released its earnings data on Thursday, July 31st. The company reported $0.30 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.29 by $0.01. The company had revenue of $141.82 million for the quarter, compared to the consensus estimate of $141.95 million. During the same quarter in the prior year, the company posted $0.31 earnings per share. The company’s quarterly revenue was up 15.1% on a year-over-year basis. Analysts expect that The Advisory Board Company will post $1.24 EPS for the current fiscal year.

ABCO has been the subject of a number of recent research reports. Analysts at FBR Capital Markets initiated coverage on shares of The Advisory Board Company in a research note on Thursday, August 14th. They set a “market perform” rating and a $50.00 price target on the stock. Analysts at Raymond James reiterated an “outperform” rating on shares of The Advisory Board Company in a research note on Friday, August 1st. They now have a $55.00 price target on the stock, down previously from $57.00. Two analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The Advisory Board Company has a consensus rating of “Buy” and a consensus target price of $67.14.

The Advisory Board Companyprovides best practices research and analysis, software tools, and management and advisory services to the health care and education industries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.